Litigation Details for AMGEN INC v. SANDOZ INC. (D.N.J. 2018)
✉ Email this page to a colleague
AMGEN INC v. SANDOZ INC. (D.N.J. 2018)
Docket | ⤷ Sign Up | Date Filed | 2018-06-26 |
Court | District Court, D. New Jersey | Date Terminated | |
Cause | 15:1126 Patent Infringement | Assigned To | Michael Andre Shipp |
Jury Demand | None | Referred To | Douglas Arpert |
Patents | 6,962,940; 7,208,516; 7,427,638; 7,659,302; 7,893,101; 8,455,536; 8,802,717; 9,018,243; 9,872,854 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in AMGEN INC v. SANDOZ INC.
Biologic Drugs cited in AMGEN INC v. SANDOZ INC.
The biologic drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .
Details for AMGEN INC v. SANDOZ INC. (D.N.J. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2018-06-26 | 1 | Complaint | United States Patent Nos. 6,962,940 (“the ’940 Patent”), 7,208,516 (“the ’516 Patent”), 7,427,638 (“… U.S. Patent Nov. 8, 2005 Sheet 1 of 2 US 6,962,940 B2 …PageID: 71 U.S. Patent Nov. 8, 2005 Sheet 2 of 2 US 6,962,940 B2 … US 6,962,940 B2 Muller et al. (45) Date… US 6,962,940 B2 | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |